Immunohistochemical based molecular subtypes of muscle-invasive bladder cancer: association with HER2 and EGFR alterations, neoadjuvant chemotherapy response and survival
Muscle-invasive bladder cancers (MIBCs) is a group of molecularly heterogonous diseases that could be stratified into subtypes with distinct clinical courses and sensitivities to chemotherapy. Clinical applica...
Source: Diagnostic Pathology - Category: Pathology Authors: Duaa S. Helal, Sara A. Darwish, Radwa A. Awad, Dina A. Ali and Dina M. El-Guindy Tags: Research Source Type: research
More News: Bladder Cancer | Cancer | Cancer & Oncology | Chemotherapy | HER2 | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Pathology